STOCK TITAN

Bionexus Gene La (BGLC) Net Income by Year

BGLC

Bionexus Gene La reported a net loss of $3.0M in fiscal year 2025. This represents a decrease of 86.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $2.6M net loss. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Bionexus Gene La has filed alongside them.

FY2025 annual
Net Income -$3.0M
YoY -86.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BGLC Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Net Income-$2.6M-$3.0M-86.7%-$1.6M+39.2%-$2.6M-638.6%-$356K-147.4%$752K-31.3%$1.1M+543.9%-$246K-1031.7%$26K

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

BGLC Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$286K+53.5%-$544K+12.8%-$1.0M-197.5%-$709K+47.3%-$616K-409.5%-$623K-500.8%-$348K-212.9%-$1.3M+48.4%$199K+176.8%-$104K-50.2%$308K+296.5%-$2.6M-3271.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Bionexus Gene La financials

Frequently Asked Questions

What was Bionexus Gene La's net income in fiscal year 2025?

Bionexus Gene La reported a net loss of $3.0M in fiscal year 2025.

How fast is Bionexus Gene La's net income growing?

Bionexus Gene La (BGLC) net income fell by 86.7% year over year, from -$1.6M to -$3.0M in fiscal year 2025.

What is Bionexus Gene La's net income over the last twelve months?

Bionexus Gene La (BGLC) reported a $2.6M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 8 fiscal years this page covers, Bionexus Gene La (BGLC) net income went from $26K in fiscal year 2018 to -$3.0M in fiscal year 2025.

Bionexus Gene La (BGLC) reported -$286K in net income in Q2 2026. This represents an increase of 53.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Bionexus Gene La (BGLC) reported on that line in every period on record.